Cambridge

Horizontal Tabs

Treatment Modalities 
Cytotoxic therapeutics
Immunotherapy
Molecular Targeted Therapies
Radiotherapy
Surgery
Facilities/Translational Research 
Phase 1 Capability
  • Phase 1 population: Both solid tumours and haematology, adult
  • Phase 1 Mechanisms: Taxanes, TKI inhibitors, Kudos compound
  • First-in-Man studies
  • Centre specific translational research interest: Molecular imaging, clinical genomics
  • Multi-centre Phase 1 studies
Technology/equipment available within the centre
  • 3T MRI facility
  • Genomics and bioinformatics
  • Molecular pathology
  • Equipment for isolation of circulating tumour cells
Other Facilities
  • Wellcome Trust CRF
  • Cambridge Breast Cancer Research Unit
  • Cambridge Cancer Clinical Trials Centre

 

Sample collection
  • Tissue Banking Activity: Addenbrooke's Tissue Bank
  • Centre contact responsible for sample collection: Professor Peter Collins

 

ECMC funding provides infrastructure support for early phase and translational research.  From the ECMC Cambridge portfolio, the following trials have been carried out.

 
Trial activity between 2012-2015:

Trial by disease type between 2012-2015: